← Back to Search

Behavioural Intervention

Reminder App for High Blood Pressure

N/A
Recruiting
Led By Jaclyn Schwartz, PhD
Research Sponsored by Washington University School of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 days
Awards & highlights

Study Summary

This trial will see if an app-based reminder and monitoring system can help 45 million US adults with hypertension take their medication as prescribed, reducing morbidity and mortality.

Who is the study for?
This trial is for adults with high blood pressure who have been on antihypertensive meds for at least a year, can use a smartphone app without help, and score low on a medication adherence scale. It's not for those needing assistance with meds, having severe cognitive or visual impairments, using pillboxes, or lacking compatible smartphones.Check my eligibility
What is being tested?
The study tests if a mobile phone app reminding patients to take their blood pressure medications improves adherence over usual care (receiving an educational pamphlet). Participants are randomly assigned to either the reminder app group or control group for 30 days while usage is tracked via special pill bottle caps.See study design
What are the potential side effects?
Since this trial involves the use of an app rather than medication, there are no direct medical side effects. However, participants may experience frustration or stress if they encounter technical difficulties with the app.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Exit interview
Medication Event Monitoring System (MEMS) Cap

Trial Design

2Treatment groups
Active Control
Group I: Medication Reminder App + MEMS CapActive Control1 Intervention
Intervention group that will be shown how to use the mobile phone medication reminder app and be given assistance downloading and setting it up on their personal phone.
Group II: MEMS Cap OnlyActive Control1 Intervention
If the participant is randomized to the control group, they will: receive a brief education session and be handed a flyer about the importance of medication adherence receive a MEMS cap and be given instructions on how to use it with their blood pressure medication

Find a Location

Who is running the clinical trial?

Washington University School of MedicineLead Sponsor
1,937 Previous Clinical Trials
2,299,662 Total Patients Enrolled
Jaclyn Schwartz, PhDPrincipal InvestigatorWashington University School of Medicine
1 Previous Clinical Trials
15 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this trial continue to accept new participants?

"Clinicaltrials.gov exhibits that this study, originally posted on September 1st 2023 and most recently updated 11 days later, is not recruiting patients at the moment. Nonetheless, there are 833 other clinical trials presently enrolling participants."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Pill Bottle vs Reminder App
2023. "Pill Bottle vs Reminder App". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06034301.
~0 spots leftby May 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top